Quantification of renal function following stereotactic body radiotherapy for pancreatic cancer: secondary dosimetric analysis of a prospective clinical trial

BACKGROUND: This is the first known study examining renal function following stereotactic body radiotherapy (SBRT) for pancreatic head adenocarcinoma. METHODS: Thirty-eight borderline-resectable/unresectable patients, part of an ongoing prospective trial, underwent 3 cycles of gemcitabine/5-fluorour...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Vivek, Bhirud, Abhijeet R., Denniston, Kyle A., Bennion, Nathan R., Lin, Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408412/
https://www.ncbi.nlm.nih.gov/pubmed/28449702
http://dx.doi.org/10.1186/s13014-017-0798-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408412/
https://www.ncbi.nlm.nih.gov/pubmed/28449702
http://dx.doi.org/10.1186/s13014-017-0798-8

Ejemplares similares